Medtech companies will need to collaborate more closely with other parties in healthcare, as the aftermath of the coronavirus pandemic will have a comprehensive reach throughout the entire ecosystem. MTI speaks with Johnson & Johnson VP Raymond Fryrear, M.D. on the topic.
Launched by AdvaMed, the platform was developed in collaboration with partners that include the Aerospace Industries Association and Google.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
Treatment can no longer be one dimensional.
Medtech decision makers must accurately predict future trends in order to chart the best future directions and identify the most advantageous areas for business investment.
There are several critical questions that your internal team should be ready to address when preparing product portfolios and seeking out a CRO.
‘Value’ is the common thread in PwC’s annual report on top health industry trends.
The search for better ways to stop bleeding may benefit from international partnerships.
Device companies will need to assess their business model in order to compete in an outcomes-based reimbursement environment.
Following these strategies will change how your company works with its outsourcing partners.